Related Experiment Video
Updated: May 11, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Next-Generation Sequencing in Oncology-A Guiding Compass for Targeted Therapy and Emerging Applications
Laurenția Nicoleta Galeș1,2, Mihai-Andrei Păun1, Ioana Butnariu1,3
1"Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Abstract:
Multigene sequencing technologies provide a foundation for targeted therapy and precision oncology by identifying actionable alterations and enabling the development of treatments that substantially improve clinical outcomes. This review emphasizes the importance of having a molecular compass guiding treatment decision-making through the multitude of alterations and genetic mutations, showcasing why NGS plays a pivotal role in modern oncology.
Insights
Multigene sequencing, like next-generation sequencing (NGS), identifies genetic mutations for targeted cancer therapies. This molecular guidance improves treatment decisions and patient outcomes in precision oncology.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Multigene sequencing technologies are crucial for advancing precision oncology.
- Identifying actionable genetic alterations is key to developing effective targeted therapies.
Purpose of the Study:
- To highlight the pivotal role of next-generation sequencing (NGS) in modern oncology.
- To emphasize the importance of molecular profiling in guiding cancer treatment decisions.
Main Methods:
- This review synthesizes current knowledge on multigene sequencing in oncology.
- Focuses on the application of NGS for identifying genetic mutations and guiding therapy.
Main Results:
- NGS enables the identification of a wide range of actionable alterations.
- Molecular profiling acts as a compass for navigating complex genetic landscapes in cancer.
Conclusions:
- NGS is indispensable for targeted therapy and precision oncology.
- Molecular guidance through NGS significantly improves clinical outcomes for cancer patients.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Targeted Cancer Therapies
There are several types of targeted therapies against...
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Sanger Sequencing